Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 16 of 16 entries
View as:

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis

Phase: N/A Priority: Normal
NCT ID: NCT00111514 Org: User:
Start: 07/31/04 End: 05/31/06 Due: 05/31/07

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis

Phase: N/A Priority: Normal
NCT ID: NCT00111553 Org: User:
Start: 10/31/04 End: 08/31/06 Due: 08/31/07

Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02071758 Org: User:
Start: 04/30/14 End: 12/31/15 Due: 12/31/16

Safety and Immunogenicity of the LEISH-F2 + MPL-SE Vaccine With SSG for Patients With PKDL

Phase: N/A Priority: Normal
NCT ID: NCT00982774 Org: User:
Start: 04/30/09 End: 04/30/11 Due: 04/30/12

Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India

Phase: N/A Priority: Normal
NCT ID: NCT00486382 Org: User:
Start: 04/30/07 End: 11/30/08 Due: 11/30/09

Phase 1 LEISH-F3 Vaccine Trial in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01484548 Org: User:
Start: 01/31/12 End: 05/31/13 Due: 05/31/14

Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03722472 Org: User:
Start: 10/02/18 End: 06/15/20 Due: 06/15/21

Phase 1 LEP-F1 + GLA-SE Vaccine Trial in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03302897 Org: User:
Start: 10/02/17 End: 03/05/19 Due: 03/05/20

Phase 2a ID93 + GLA-SE Vaccine Trial in TB Patients After Treatment Completion

Phase: N/A Priority: Normal
NCT ID: NCT02465216 Org: User:
Start: 06/30/15 End: 01/31/17 Due: 01/31/18

Phase 1 ID93 + GLA-SE Vaccine Trial in BCG-Vaccinated Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01927159 Org: User:
Start: 09/30/13 End: 07/31/15 Due: 07/31/16

Phase 1 ID93 + GLA-SE Vaccine Trial in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01599897 Org: User:
Start: 08/31/12 End: 05/31/14 Due: 05/31/15

A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis

Phase: N/A Priority: Normal
NCT ID: NCT01011309 Org: User:
Start: 10/31/09 End: 12/31/11 Due: 12/31/12

The Effects of GLA (5 mcg) on Human Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01864876 Org: User:
Start: 09/30/12 End: 12/31/13 Due: 12/31/14

H5-VLP + GLA-AF Vaccine Trial in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01657929 Org: User:
Start: 09/30/12 End: 01/31/14 Due: 01/31/15

Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite

Phase: N/A Priority: Normal
NCT ID: NCT00121862 Org: User:
Start: 08/31/05 End: 03/31/06 Due: 03/31/07

Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite

Phase: N/A Priority: Normal
NCT ID: NCT00121849 Org: User:
Start: 08/31/05 End: 02/28/06 Due: 02/28/07